Effects of genistein and 2-methoxyestradiol on matrix metalloproteinases and their inhibitors secreted by Ehrlich ascites tumor cells

被引:0
作者
Fajardo, I [1 ]
Díez, E [1 ]
Rodríguez-Nieto, S [1 ]
Rodríguez-Caso, C [1 ]
Quesada, AR [1 ]
Sánchez-Jiménez, F [1 ]
Medina, MA [1 ]
机构
[1] Univ Malaga, Fac Ciencias, Dept Biol Mol & Bioquim, E-29071 Malaga, Spain
关键词
matrix metalloproteinases; tissue inhibitor of matrix metalloproteinase; genistein; 2-methoxyestradiol; Ehrlich cells;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Ehrlich ascites tumor is an experimental tumor model very suitable for performing comparative studies relating its growth in vitro and in vivo. We used this armor model to study the potential modulatory effects of genistein and 2-methoxyestradiol, two anti-angiogenic compounds, on the proteolytic balance MMP/TIMP. Ehrlich cells grown in vitro secreted MMP-9, MMP-2 and two TIMPs; the treatment with either of the anti-angiogenic compounds here tested stimulated all these activities, but the increase in TIMPs activities of genistein-treated cells were higher than those of MMPs, thus inducing a decrease in the proteolytic balance. On the other hand, Ehrlich cells growing in vivo did not produce any detectable TIMP activity, brit accumulated MMP-9 and MMP-2 during tumor growth. Both compounds induced significant decrease of MMPs activity when tumor cells were actively proliferating. It was concluded that both genistein and 2-methoxyestradiol could shift the proteolytic balance MMP/TIMP towards antiproteolysis in media ol ascitic fluid conditioned by actively growing Ehrlich cells.
引用
收藏
页码:1691 / 1694
页数:4
相关论文
共 22 条
[1]  
AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
[2]   PLASMINOGEN-ACTIVATOR INHIBITORS - HORMONALLY REGULATED SERPINS [J].
ANDREASEN, PA ;
GEORG, B ;
LUND, LR ;
RICCIO, A ;
STACEY, SN .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 68 (01) :1-19
[3]  
[Anonymous], 1983, J IMMUNOL METH
[4]  
BARNES S, 1994, ADV EXP MED BIOL, V354, P135
[5]  
BLASI F, 1986, HUMAN GENES DISEASES, P377
[6]  
DAN K, 1985, ADV CANCER RES, V44, P139
[7]   Modulation of the proteolytic balance plasminogen activator plasminogen activator inhibitor by enhanced N-myc oncogene expression or application of genistein [J].
de Veas, RG ;
Schweigerer, L ;
Medina, MA .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (11) :1736-1740
[8]  
DVORAK HF, 1991, CANCER CELL-MON REV, V3, P77
[9]  
EDMONARD H, 1990, CELL MOL BIOL, V36, P131
[10]   A comparative study of the effects of genistein and 2-methoxyestradiol on the proteolytic balance and tumour cell proliferation [J].
Fajardo, I ;
Quesada, AR ;
de Castro, IN ;
Sánchez-Jiménez, F ;
Medina, MA .
BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) :17-24